Navigation Links
LCA-Vision Reports 2011 Second Quarter Procedure Volume
Date:7/6/2011

CINCINNATI, July 6, 2011 /PRNewswire/ -- LCA-Vision Inc. (NASDAQ: LCAV), a leading provider of laser vision correction services under the LasikPlus® brand, today reported that 14,081 procedures were performed during the second quarter of 2011, compared with 15,266 procedures (62 vision centers) during the second quarter of 2010.  Same-store procedures (53 vision centers) increased slightly year-over-year from 13,943 procedures during the second quarter of 2010, the third consecutive quarter of year-over-year same-store procedure growth.

LCA-Vision will release second quarter 2011 financial results prior to market opening on Tuesday, July 26, 2011.  A conference call and webcast to discuss the results also will be held on Tuesday, July 26, 2011 at 10:00 a.m. Eastern Time.

To access the conference call, dial 866-322-1352 (within the United States and Canada), or 706-643-6246 (international callers).  The webcast will be available at the investor relations section of LCA-Vision's website.  A replay of the call and webcast will begin approximately two hours after the live call has ended.  To access the replay, dial 800-642-1687 (within the United States and Canada), or 706-645-9291 (international callers) and enter the conference ID number: 78217237.

About LCA-Vision Inc./LasikPlus®LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 53 LasikPlus® fixed-site laser vision correction centers in 26 states and 41 markets in the United States.  Additional company information is available at www.lca-vision.com and www.lasikplus.com. Earning Trust Every Moment;Building Relationships for a Lifetime.For Additional InformationCompany Contact:Investor Relations Contact:Barb Kise

Jody CainLCA-Vision Inc.

Lippert/Heilshorn & Associates513-792-9292

310-691-7100
'/>"/>

SOURCE LCA-Vision Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes
2. ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
3. BioDrain Medical, Inc. Reports Results of Annual Meeting
4. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
5. Enzymatics Reports Latest Growth Figures; Confirms Massachusetts Emerging Role as Leading Bio-manufacturing Center
6. Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales
7. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
8. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9. Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance
10. China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
11. Encision Reports Profitable Fourth Quarter and Fiscal Year 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
(Date:5/4/2017)... Tenn. , May 4, 2017  A ... Infection Control, Ultraviolet-C light as a ... Tru-D SmartUVC,s ability to reduce bioburden on anesthesia ... bioburden reduction on high-touch, complex medical equipment surfaces ... surgical infections. "This study further validates ...
(Date:5/4/2017)... May 4, 2017  A new tight-tolerance microextrusion ... other highly-engineered materials, is being launched by Natvar, ... been developed in recent years to service a ... surgical applications. More expensive materials such as glass ... tubing due to their ability to consistently hold ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... , ... Amir Qureshi, MD is the first physician in Arkansas to implant ... The Nuvectra™ Algovita SCS System has been FDA approved as a treatment option for ... to introduce the most powerful SCS system and the only stretchable lead on the ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community health data ... are located in the Midwest. With the average cost of healthcare rising and the ... with both the quality and affordability of where they live. An annual 2017 report ...
(Date:5/26/2017)... ... May 26, 2017 , ... via seating is proud to ... task chair specifically designed for clinical areas. Genie Copper Mesh is a crossover ... Cupron® to provide customers with a game changing chair that is affordably priced,” ...
(Date:5/26/2017)... ... ... After raising nearly $30,000 on Kickstarter , about three-times its original campaign ... crowdfunding price on Indiegogo . , “Along with creating an anti-stress gadget to ... fidget toy to the market that was made of superior quality and wouldn’t break ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Silver Birch ... community, which is located on more than four acres of land at 5620 Sohl ... , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each of ...
Breaking Medicine News(10 mins):